The rationale for the use of BEZAFIBRATE to control abnormal elevations of serum lipids and lipoproteins is to reduce or prevent the long-term adverse effects which have been shown by many major epidemiological studies to be positively and strongly correlated with such dyslipidaemias. The possible beneficial and adverse long-term consequences of some drugs used in the hyperlipidaemias are still the subject of scientific discussion, however, and there is currently no clinical evidence to demonstrate that BEZAFIBRATE is effective in the prevention of heart disease.
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $139 a year.
Sign Out
